The latest trend in treating hair loss may sound familiar — essentially, it's a repurposed drug first popularized in the ...

The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...

The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...

The topical form was approved for hair loss by the FDA in 1988, the first drug to win the agency's endorsement for male ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a ...

Hims & Hers is shutting down the dermatology ... including treatments for hair loss, erectile dysfunction, and mental health, said shuttering Apostrophe would help it centralize its skincare ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...

But with GLP-1 sales vanishing, Hims is left banking on generic weight-loss pills and its core business in hair-loss and ED treatments. While that business is solid, it doesn't justify the lofty ...